Stock Earnings

Question 1

What are Corcept Therapeutics Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Corcept Therapeutics Inc has a total asset of $840, Net profit of $141

Question 2

What are the key financial ratios for CORT?

Accepted Answer

Corcept Therapeutics Inc's Current ratio is 5.25, has a Net margin is 20.88, sales per share of $5.94.

Question 3

How is Corcept Therapeutics Inc's revenue broken down by segment or geography?

Accepted Answer

Corcept Therapeutics Inc largest revenue segment is Pharmaceutical, at a revenue of 675,040,000 in the most earnings release.For geography, United States is the primary market for Corcept Therapeutics Inc, at a revenue of 675,040,000.

Question 4

Is Corcept Therapeutics Inc profitable?

Accepted Answer

yes, according to the latest financial statements, Corcept Therapeutics Inc has a net profit of $141

Question 5

Does Corcept Therapeutics Inc have any liabilities?

Accepted Answer

yes, Corcept Therapeutics Inc has liability of 160

Question 6

How many outstanding shares for Corcept Therapeutics Inc?

Accepted Answer

Corcept Therapeutics Inc has a total outstanding shares of 105.11

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	741	675	482	401	366	353
Revenue Growth (YoY)	18%	40%	20%	10%	4%	15%
Cost of Revenue	13	10	6	5	5	5
Gross Profit	727	664	475	396	360	348
Selling, General & Admin	401	280	184	152	122	105
Research & Development	260	246	184	131	113	114
Operating Expenses	662	527	368	283	236	220
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	88	161	124	116	125	131
Income Tax Expense	-17	20	18	14	12	25
Net Income	106	141	106	101	112	106
Net Income Growth	-25%	33%	5%	-10%	6%	13%
Shares Outstanding (Diluted)	119.43	113.48	111.74	116	126	124.2
Shares Change (YoY)	5%	2%	-4%	-8%	1%	1%
EPS (Diluted)	0.88	1.24	0.94	0.87	0.89	0.85
EPS Growth	-28.99%	31%	9%	-2%	5%	10%
Free Cash Flow	162	195	126	119	167	150
Free Cash Flow Per Share	1.35	1.71	1.12	1.02	1.32	1.2
Gross Margin	98.11%	98.37%	98.54%	98.75%	98.36%	98.58%
Operating Margin	8.77%	20.14%	22.19%	27.93%	33.87%	36.26%
Profit Margin	14.3%	20.88%	21.99%	25.18%	30.6%	30.02%
Free Cash Flow Margin	21.86%	28.88%	26.14%	29.67%	45.62%	42.49%
EBITDA	65	136	108	112	125	128
EBITDA Margin	8.77%	20.14%	22.4%	27.93%	34.15%	36.26%
D&A For EBITDA	0	0	1	0	1	0
EBIT	65	136	107	112	124	128
EBIT Margin	8.77%	20.14%	22.19%	27.93%	33.87%	36.26%
Effective Tax Rate	-19.31%	12.42%	14.51%	12.06%	9.6%	19.08%

Corcept Therapeutics Inc (CORT) Price

CORT Stock Price Chart

CORT Income

Follow-Up Questions